ICYMI: Thanks to CBC’s Quirks and Quarks for re-running this November 2020 interview with our co-founder, Dr. Molly Shoichet.
She spoke with Bob McDonald about winning the Gerhard Herzberg Canada Gold Medal and her research in hydrogel materials. AMT-143, our lead product, is grounded in this research and is currently approved for a Phase I clinical trial.
Listen to the interview or read the news story.
adMare BioInnovations is pleased to announce the nine women and nine men from diverse backgrounds and representing a wide range of life science businesses across the country, selected to join this year’s adMare Academy Executive Institute.Read more
Amacathera Inc. has been named a Canadian Innovation Exchange (CIX)’s Top 20 Early company for 2021.Read more
Globe and Mail features AmacaThera’s Series A financingRead more